Abcam’s aim is to serve life science researchers to achieve their mission, faster. We continuously listen, collaborate and support the scientific community in order to improve and offer new affinity binders, reagents, biomarkers and assays that will drive greater scientific progress.
Our culture is a key differentiator. We believe in empowering individuals, with responsibility given at an early stage. The working environment is fun and fast-paced, collaborative and outcome focused, with a strong customer focus. In addition to competitive salaries we offer an attractive flexible benefits package with plenty of opportunities to learn and grow.
Our head office is in Cambridge (UK), we also have offices in Bristol (UK), Cambridge, Eugene and San Francisco (USA), Tokyo (Japan), Hong Kong, Hangzhou and Shanghai (China).
We have a range of roles in IT background and would normally look for candidates with a degree in computer science or other numerate disciplines. We also recruit positions for candidates with a scientific background and we would normally look for candidates with biological science qualifications.
Show more| Type | Public |
| HQ | Milton, GB |
| Founded | 1998 |
| Size (employees) | 948 (est)+8% |
| Website | abcam.com |
Abcam was founded in 1998 and is headquartered in Milton, GB
Report incorrect company information
Viewing summary data as a guest
Sign up for free to see all dataKey People/Management at Abcam
Jonathan Milner
CEO
Report incorrect company information
Abcam Office Locations
Abcam has offices in Milton, Cambridge, Bristol, Sydney and in 8 other locations
Milton, GB (HQ)
330 Cambridge Science Park Milton Rd
Cambridge, US (HQ)
b2304 One Kendall Square Binney St
Shanghai, CN
Galileo Rd. Pudong
Tokyo, JP
2-2-1 Nihonbashi Horidome-cho
Cambridge, US
b2304 1 Kendall Square
Report incorrect company information
Abcam Financials and Metrics
Abcam Revenue
Abcam's revenue was reported to be £233.20 m in FY, 2018
| GBP | |
|---|---|
Revenue (FY, 2018) | 233.2m |
Gross profit (FY, 2018) | 163.0m |
Gross profit margin (FY, 2018), % | 69.9% |
Net income (FY, 2018) | 62.2m |
EBITDA (FY, 2018) | 84.2m |
EBIT (FY, 2018) | 68.8m |
Cash (30-Jun-2018) | 90.2m |
| GBP | FY, 2000 | FY, 2001 | FY, 2002 | FY, 2003 | FY, 2004 | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 248.4k | 719.6k | 1.8m | 3.5m | 6.7m | 12.1m | 19.4m | 24.5m | 36.7m | 56.8m | 71.1m | 83.3m | 97.8m | 122.2m | 128.0m | 144.0m | 171.7m | 217.1m | 233.2m |
Revenue growth, % | 13% | 19% | |||||||||||||||||
Cost of goods sold | 160.4k | 416.1k | 820.6k | 1.4m | 2.5m | 4.7m | 7.5m | 10.0m | 14.4m | 19.4m | 23.7m | 27.2m | 30.3m | 35.5m | 37.6m | 42.5m | 51.1m | 65.0m | 70.2m |
Gross profit | 88.0k | 303.5k | 983.7k | 2.1m | 4.2m | 7.5m | 11.9m | 14.5m | 22.3m | 37.4m | 47.4m | 56.0m | 67.6m | 86.7m | 90.4m | 101.5m | 120.5m | 152.1m | 163.0m |
| GBP | FY, 1999 | FY, 2000 | FY, 2001 | FY, 2002 | FY, 2003 | FY, 2004 | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 9.6k | 269.1k | 87.3k | 59.1k | 66.1k | 274.3k | 510.0k | 884.0k | 2.2m | 13.5m | 25.5m | 40.2m | 55.6m | 14.0m | 37.3m | 55.3m | 57.1m | 68.9m | 84.8m | 90.2m |
Accounts Receivable | 55.1k | 158.6k | 261.0k | 424.8k | 926.8k | 1.7m | 2.4m | 3.3m | 3.7m | 5.4m | 6.8m | 7.9m | 11.5m | 12.1m | 13.2m | 19.6m | 22.0m | 24.9m | ||
Inventories | 3.2k | 4.0k | 18.1k | 69.4k | 185.9k | 557.8k | 1.2m | 2.4m | 3.1m | 4.5m | 6.8m | 9.1m | 10.7m | 15.4m | 15.3m | 14.8m | 19.8m | 19.7m | 21.8m | 29.6m |
Current Assets | 33.6k | 362.3k | 320.8k | 696.5k | 864.3k | 2.7m | 4.6m | 17.0m | 18.1m | 23.9m | 40.1m | 58.5m | 76.4m | 48.7m | 71.3m | 90.9m | 100.5m | 119.7m | 143.5m | 159.9m |
| GBP | FY, 2000 | FY, 2001 | FY, 2002 | FY, 2003 | FY, 2004 | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (190.1k) | (471.9k) | (328.2k) | 517.2k | 1.0m | 2.3m | 3.7m | 4.1m | 5.9m | 12.3m | 19.2m | 23.8m | 25.4m | 32.7m | 34.0m | 37.4m | 37.4m | 42.4m | 62.2m |
Cash From Operating Activities | 2.6m | 3.5m | 4.9m | 7.1m | 14.8m | 19.7m | 25.5m | 24.5m | 39.4m | 41.3m | 40.2m | 47.3m | 66.4m | 63.3m | |||||
Dividends Paid | 300.0k | 1.3m | 1.2m | 968.0k | 2.6m | 5.3m | 7.9m | 10.1m | 12.5m | 11.3m | 15.9m | 16.7m | 19.1m | 22.1m | |||||
Cash From Financing Activities | 570.0k | 9.3m | 47.0k | (2.2m) | (1.2m) | (27.4m) | (7.6m) | 10.7m | (11.8m) | (13.8m) | (14.1m) | (15.4m) | (17.8m) | (20.6m) |
| GBP | Y, 2018 |
|---|---|
Financial Leverage | 1.2 x |
Report incorrect company information
Abcam Online and Social Media Presence
5.57k Twitter followers
Abcam has 5.57k Twitter Followers. The number of followers has increased 0.5% month over month and increased 1.5% quarter over quarter
Report incorrect company information
Abcam News and Updates
January 15, 2019
Detailed Examination of the Global Life Science Reagent Market Forecast to 2025: High Throughput Genomics Inc., Illumina Inc., Abbott Laboratories, Abcam
Life Science Reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading. These reagents are used in the field of research, diagnosis, bioscience, and education. Posted via Industry Today. Follow us on Twitter @IndustryToday
December 24, 2018
5-Aminolevulinic Acid Hydrochloride Global Market 2018 Top Key Players – Formedium , Arisun ChemPharm, Cayman Chemical, Abcam, AdooQ BioScience and Forecast to 2025
Wiseguyreports.Com Added New Market Research Report On -“Global 5-Aminolevulinic Acid Hydrochloride Market 2018 Top Key Players, Production , Growth and Future Demand Forecast to 2025 ”. Posted via Industry Today. Follow us on Twitter @IndustryToday
November 30, 2018
MicroRNM Global Market 2018 Top Key Players – Abcam Plc , Illumina, Inc. , Agilent Technologies , Bio-Rad Laboratories Inc. , Sigma Aldrich Corp. and Forecast to 2025
Wiseguyreports.Com Added New Market Research Report On -“Global MicroRNM Market 2018 Top Key Players, Production , Growth and Future Demand Forecast to 2025 ”. Posted via Industry Today. Follow us on Twitter @IndustryToday
November 16, 2018
Global Mammalian Polyclonal IgG Antibody Market Analysis Report 2018 Featuring Abcam, Bio-Rad Labs, Thermo Fisher Scientific, Merck, Cell Signaling Technologies Hoffmann-La Roche
DUBLIN, Nov. 16, 2018 /PRNewswire/ -- The "Mammalian Polyclonal IgG Antibody Market Size, Share & Trends Analysis Report By Type (Mouse, Rabbit), By Product (Cardiac, Metabolic), By Application, By End Use, By Region, And Segment Forecasts, 2018 - 2025" report has been added to...
October 30, 2018
Life Science Tools & Reagents Global Market 2018 Top Key Players – Abbott Laboratories, Abcam , BD Biosciences , Beckman Coulter Inc. , Benitec , Bio-Rad Laboratories , Cell Sciences and Forecast to 2023
Wiseguyreports.Com Added New Market Research Report On -“Life Science Tools & Reagents Market 2018 Key Players, Applications and Future Demand Forecast to 2023 ”. Posted via Industry Today. Follow us on Twitter @IndustryToday
July 23, 2018
Alpha-lactalbumin Market : Industry Perspective and Comprehensive Analysis 2024
Persistence Market Research has announced the addition of the “Alpha-lactalbumin Market: Global Industry Analysis and Opportunity Assessment 2016 - 2024" report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information
Abcam Blogs
January 17, 2019
Cell image doppelgängers
Yeah, that’s right: cell image doppelgängers! We’ve all seen the hidden pictures within our imaging results. Maybe it’s the long hours staring down the microscope, the “long lunches”, or maybe all the mulled wine and mince pies this time of year, but we can totally see a host of doppelgängers lurkin…
December 13, 2018
Grad school, The Bachelor, and expectations for scientists
I love “The Bachelor.” Most of my Instagram feed is posts from “Bachelor” alums (and therefore ads for Sugar Bear hair vitamins) and I can rattle off my personal ranking of best to worst bachelors without hesitation (best: Sean Lowe, worst: Ari Luyendyk and do not challenge me on this). Watching the…
December 06, 2018
20 years of sciencing
In case you didn’t know, Abcam turned 20 this year. To celebrate, we went ahead and put together a list of some of the best discoveries and breakthroughs as chosen by the science community – with some gorgeous artwork to accompany it. Because science is awesome, as we all know. Here’s a selection of…
November 09, 2018
Scicomm: is it your duty to communicate your research?
Last month we had the pleasure of hosting a panel discussion at the Crick in London with the wonderful Rob de Bruin, Anna Ploszajski and Kath Nightingale. Thanks to our speakers and everyone who attended!
The post Scicomm: is it your duty to communicate your research? appeared first on Tipbox.
October 25, 2018
Tips to avoid the dreaded Burn Out
Being a graduate student is grueling, tiresome work. Most of us work ten to twelve-hour days during the week, and even throwing in some weekend hours. All done in the name of science, and so that we can stick it to Reviewer Number One, who won’t believe your data until you do that fifth control […]
…
September 27, 2018
The Social Scientist
I think it’s safe to say that all of us, at some point or another, have struggled with “networking.” Let’s face it: as scientists, we often work in isolation and so meeting the right people to discuss work or even collaborate with, can be challenging. It’s also incredibly awkward for a lot of us! Th…
Abcam Company Life and Culture
Report incorrect company information
Abcam Frequently Asked Questions
When was Abcam founded?
Abcam was founded in 1998.
Who are Abcam key executives?
Abcam's key executives are Jonathan Milner.
How many employees does Abcam have?
Abcam has 948 employees.
What is Abcam revenue?
Latest Abcam annual revenue is £233.2 m.
What is Abcam revenue per employee?
Latest Abcam revenue per employee is £246 k.
Who are Abcam competitors?
Competitors of Abcam include Humanigen, TxCell and Foundation Medicine.
Where is Abcam headquarters?
Abcam headquarters is located at 330 Cambridge Science Park Milton Rd, Milton.
Where are Abcam offices?
Abcam has offices in Milton, Cambridge, Bristol, Sydney and in 8 other locations.
How many offices does Abcam have?
Abcam has 13 offices.